Thalassemia Treatment in India

What is Thalassemia?

Thalassemia is a type of genetic blood disorder in which the patients are not able to produce sufficient haemoglobin, resulting in red blood cells not being capable of carrying oxygen from one part of the body to another. This very condition eventually results in a process known as anemia, that is, the condition in which there is no production of any healthy red blood cells in the body.

What is the Importance of Timely Treatment?

• Avoiding Organ Damage: Iron overload following repeated blood transfusion damages organs such as the heart, liver, and endocrine glands. Iron chelation therapy is vital because it removes excess iron from the body and prevents organ damage. It also helps avoid a particular organ's failure because of timely intervention.
• Better Growth and Development Among Children: Sometimes, children suffering from thalassemia, especially severe, undergo growth retardation and bone deformities. Early diagnosis and treatment of thalassemia ensure providing nutritional support and bone health for better growth and development.
• Prevention of Complications: A delay in treatment increases the risk of such complications severely, for example, heart disease, liver disease, and abnormality of bones. Lack of timely and regular treatment can significantly contribute to these risks and the quality of life.
• Better Quality of Life: Early initiation of treatment would enable a patient to manage quite a large portion of the symptoms and, hence, lead a more normal life. Blood transfusions, medications, and regular follow-ups could then diminish the ill effects of the disease and allow such an individual to live a busy life.

What are the Common Symptoms of Thalassemia?

• Fatigue and Weakness
• Paleness (Pallor)
• Delayed Growth and Development
• Bone Deformities
• Enlarged Organs
• Frequent Infections
• Jaundice

Causes and Risk Factors of Thalassemia

Causes

• Genetic Mutations
• Inheritance Pattern

Risk Factors:

• Family History
• Ethnic Background
• Being a Carrier (Thalassemia Trait)
• Age of Parents
• Previous Children with Thalassemia

Latest Research and Technologies in the Treatment of Thalassemia in India

The medical treatment of Thalassemia in India adapts the newest research and technologies to meet worldwide clinical standards and healthcare capabilities.

• Gene Therapy: Advances in gene therapy using CRISPR-Cas9 technology present a viable way for thalassemia patients needing correction of genetic defects to provide long-lasting cures. Presently, specific clinical trials in India have exciting prospects.
• Stem Cell and Bone Marrow Transplant: Bone marrow transplants have been approved as effective treatment options for severe thalassemia due to improvements and advancements in stem cell techniques and post-transplant care in medical centres in India.
• Iron Chelation: Newer iron chelation therapies like Deferasirox and Deferiprone are of great value in dealing with iron overload, an almost universal complication in thalassemia patients receiving multiple blood transfusions.
• Non-Invasive Screening: There is an increase in genetic and newborn screening programs in India by which severe thalassemia can be diagnosed and prevented as early as possible for intervention, thus decreasing the chances of birth of affected children.
• Improved Care and Awareness: A focus on comprehensive cure centres exists, providing multidisciplinary support for thalassaemia patients. In addition, public campaigns raising awareness and genetic counselling work toward reducing the prevalence of the disease in high-risk populations.

Thalassemia Prevention Tips:

• Genetic Screening and Counseling: Couples intending to start a family, mainly if they belong to high-risk ethnic groups (Mediterranean, Middle Eastern, Asian, etc.), must undergo genetic screening to test for carrier status. Genetic counseling would guide families in the decision-making process concerning family planning.
• Early Diagnosis: Screening newborns and early blood tests can identify thalassemia traits or the significant forms of the disease at an early stage. Early diagnosis will allow for better management and prevention of severe complications.
• Avoiding Marriage Between Carriers: If both parents are carriers of the thalassemia gene, there is a 25% chance of having a child with a thalassemus major. Genetic counselling should be provided to couples with family histories or known carrier status before marriage or pregnancy.
• Prenatal Testing: For at-risk couples, prenatal testing such as chorionic villus sampling (CVS) or amniocentesis can determine if the fetus has inherited thalassemia from both parents. This allows for informed decision-making during the pregnancy.